[HTLV-1-associated myelopathy].


Journal

Uirusu
ISSN: 0042-6857
Titre abrégé: Uirusu
Pays: Japan
ID NLM: 0417475

Informations de publication

Date de publication:
2019
Historique:
entrez: 17 9 2020
pubmed: 1 1 2019
medline: 1 1 2019
Statut: ppublish

Résumé

Human T-cell leukemia virus type 1 (HTLV-1) is a retrovirus that infects T lymphocytes. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an intractable neurodegenerative disease caused by HTLV-1 infection just like adult T cell leukemia/lymphoma (ATL) is, developing in a fraction of infected individuals. Here, we review the update information about the new drug development and therapeutic algorithm of HAM/TSP based on the resent research achievement in molecular pathogenesis and biomarkers.

Identifiants

pubmed: 32938892
doi: 10.2222/jsv.69.29
doi:

Types de publication

English Abstract Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

29-36

Auteurs

Yoshihisa Yamano (Y)

Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine.

Classifications MeSH